Prediagnosis epilepsy and survival in patients with glioma: a nationwide population-based cohort study from 2009 to 2018

Keyphrases

• National Cohort Study 100%
• Epilepsy 100%
• Glioma 100%
• Confidence Interval 50%
• Hazard Ratio 50%
• Patients with Epilepsy 30%
• Glioma Patients 30%
• Glioma Grading 30%
• Risk of Death 20%
• Survival Benefit 20%
• High-grade Glioma 20%
• Neuro-oncology 20%
• Glioma Diagnosis 20%
• Cox Proportional Hazards Model 10%
• Decreased Risk 10%
• Prescription Registry 10%
• Treatment Modalities 10%
• Early Diagnosis 10%
• Performance Status 10%
• Favorable Prognosis 10%
• Biomarker Testing 10%
• Tumor Size 10%
• Tumor-specific 10%
• Tumor Grade 10%
• National Patient Registry 10%
• Low-grade Glioma 10%
• Adult Gliomas 10%
• Molecular Biomarkers 10%
• Glioma Survival 10%

Medicine and Dentistry

• Cohort Analysis 100%
• Ganglioglioma 100%
• Hazard Ratio 38%
• Patient with Epilepsy 23%
• Neuro-Oncology 15%
• Neoplasm 7%
• Biological Marker 7%
• Proportional Hazards Model 7%
• Early Diagnosis 7%
• Patient Registry 7%
• Histopathology 7%
• Specific Tumor 7%